EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC 3.0

Erratum to ‘Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer’ [Clin Mol Hepatol 2026;32:721-736]

Daeseong Kim, Nam Suk Sim, Seonjeong Woo, Min Hwan Kim, Choong-Kun Lee, Seung Soo Hong, Sung Hyun Kim, Ho Kyoung Hwang, Chang Moo Kang, Woo Jung Lee, Jung Hyun Jo, Taek Chung und 9 weitere

Clinical and Molecular Hepatology · 01.10.2026 · 32 (4) · e2025.1019e

DOI: 10.3350/cmh.2025.1019e ↗

Kurz gefasst

Korrektur in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.10.2026. Verfasst von Daeseong Kim und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Life Science, CHA University, Seongnam, Korea.
  • Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Division of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

Zitieren

APA

Kim, D., Sim, N. S., Woo, S., Kim, M. H., Lee, C. K., Hong, S. S., Kim, S. H., Hwang, H. K., Kang, C. M., Lee, W. J., Jo, J. H., Chung, T., Hwang, S., Kang, B., Kim, J. S., Kwon, C. I., Kim, S., Chon, H. J., Kim, C. G., …, & Choi, H. J. (2026). Erratum to ‘Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer’ [Clin Mol Hepatol 2026;32:721-736]. Clinical and Molecular Hepatology, 32(4), e2025.1019e. https://doi.org/10.3350/cmh.2025.1019e

Vancouver

Kim D, Sim NS, Woo S, Kim MH, Lee CK, Hong SS, et al. Erratum to ‘Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer’ [Clin Mol Hepatol 2026;32:721-736]. Clinical and Molecular Hepatology. 2026;32(4):e2025.1019e. doi:10.3350/cmh.2025.1019e

BibTeX
@article{Kim2026,
  author = {Kim, Daeseong and Sim, Nam Suk and Woo, Seonjeong and Kim, Min Hwan and Lee, Choong-Kun and Hong, Seung Soo and Kim, Sung Hyun and Hwang, Ho Kyoung and Kang, Chang Moo and Lee, Woo Jung and Jo, Jung Hyun and Chung, Taek and Hwang, Sohyun and Kang, Beodeul and Kim, Jung Sun and Kwon, Chang-Il and Kim, Sangwoo and Chon, Hong Jae and Kim, Chang Gon and Park, Young Nyun and Choi, Hye Jin},
  title = {Erratum to ‘Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer’ [Clin Mol Hepatol 2026;32:721-736]},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  volume = {32},
  number = {4},
  pages = {e2025.1019e},
  doi = {10.3350/cmh.2025.1019e}
}
Kostenlos starten →